ask="N/A"
ask_size="N/A"
average_daily_volume="36260"
bid="3.270"
bid_size="1400"
book_value="-0.228"
change="+0.109"
change_from_200_day_moving_average="-0.146"
change_from_50_day_moving_average="0.437"
change_from_52_week_high="-1.991"
change_From_52_week_low="1.695"
change_in_percent="+3.215%"
close="3.499"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.670"
ebitda="-49.36M"
eps_estimate_current_year="-1.260"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-1.480"
ex_dividend_date="N/A"
float_shares="12319000"
high="3.499"
high_52_weeks="5.490"
last_trade_date="2/14/2017"
last_trade_price="3.499"
last_trade_size="270"
last_trade_time="3:45pm"
low="3.380"
low_52_weeks="1.804"
market_capitalization="82.50M"
moving_average_200_day="3.645"
moving_average_50_day="3.062"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.000"
open="3.380"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-3.993%"
percent_change_from_50_day_moving_average="+14.278%"
percent_change_from_52_week_high="-36.266%"
percent_change_from_52_week_low="+93.969%"
previous_close="3.390"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="26.826"
revenue="2.98M"
shares_outstanding="23578000"
short_ratio="1.110"
stock_exchange="NGM"
symbol="ONS"
volume="1941"
weeks_range_52="1.804 - 5.490"
